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Background.Theprevalenceoffecalincontinencevariestremendouslyasaresultofinadequatedatacollectionmethods.Fewoﬃce-
basedstudies haveassessedthe prevalence offecalincontinenceandnonehavelookedatmodiﬁableriskfactors oreﬀect onquality
of life. Design, Settings, Patients, and Main Outcome Measures. Five hundred patients who visited our inner city, university-based
gastroenterologypractice, wereaskedaboutsymptomsoffecalincontinence.Wealsoretrospectively reviewed 500chartstoidentify
the frequency of patient-physician reporting of fecal incontinence. Results. Of the 500 patients that were directly questioned, 58
(12%, 43 women, 15 men) admitted to fecal incontinence compared to 12 (2.4%) in the retrospective arm. Patients with fecal
incontinence and loose/watery stool reported the lowest quality of life scores. Whilethe average severity score was similarbetween
men and women, women had a signiﬁcantly lower average quality of life score (3.04 versus 2.51; P<0.03). Conclusions.T h e
identiﬁcation of fecal incontinence increas e sw h e np a t i e n t sa r ed i r e c t l yq u e s t i o n e d .I dentifying and treating patients with loose
stool is a potential strategy to improve quality of life in this patient population. In men and women with similar severity of fecal
incontinence, women have a signiﬁcantly lower quality of life.
1.Introduction
Fecal incontinence (FI) is deﬁned as the inadvertent passage
of stool, soiling, or excessive escape of ﬂatus. The prevalence
of FI varies among studies because of diﬀering deﬁnitions
of this disorder, patients’ reluctance to report symptoms,
and inadequate data collection methods [1]. In the general
community, the prevalence ranges from 0.4% to 18% [2–
12]. Oﬃce-based studies document that 13% to 29% of
patients in primary care and specialty clinics admit to FI
when asked [7, 10, 11, 13, 14]. Studies from obstetrics
and gynecology, urogynecology, and antenatal outpatient
clinics report prevalences between 5.6% and 29% [9, 14, 15].
Johansen and Laﬀerty are the only group who has sampled
patients from primary care and gastroenterology outpatient
oﬃces. However, this study was limited to a predominantly
Caucasian population and did not evaluate the eﬀect of FI
on quality of life (QOL) [16].
The diﬀerence in prevalence of FI between men and
women has similarly yielded variable results. The discrepan-
cies are largely due to inconsistent data collection methods,
variable ages, and reluctance to report symptoms. A large-
scale systematic review found that 0.8% of men and 1.6% of
womenaged15to60yearsreportedFI.Inthoseolderthan60
years, the prevalence increased to 5.1% in men and 6.2% in
women. The most recent epidemiologicsurvey citesa similar
prevalence in men and women (8.9% versus 7.7%), whereas
other studies cite a higher prevalence in men (20% versus
11%, P<0.015) [6, 17] .N o n e ,h o w e v e r ,h a se x a m i n e dt h e
gender-speciﬁc eﬀect on symptom severity and QOL.
It is evident from the aforementioned studies that the
prevalenceriseswhenFIisdirectlyaddressed.Ifincontinence
does not pertain to the patient’s chief complaint, however,
many physiciansmaynotinquire.Unfortunately,thisperpet-
uates the “do not ask, do not tell” cycle.2 Gastroenterology Research and Practice
Better attempts to identify and treat patients with FI are
essential, especially among physicians such as internists, gy-
necologists, and gastroenterologists, who are the most likely
to treat this devastating condition.
Wehypothesizedthatwecouldincreasetheidentiﬁcation
ofpatientswithFIbydirectquestioningduringaroutinegas-
troenterologyoﬃce visit. Wealso hypothesized thatwe could
determine if the severity of FI symptoms would correlate
with quality of life. Our study intended to investigate these
two hypotheses by adding the symptom of FI to our stan-
dardized gastrointestinal review of symptoms. We intended
to evaluate QOL and severity of FI symptoms by admin-
istering validated questionnaires. In addition, we aimed to
identify modiﬁable risk factors within this population that
could be addressed and treated early to prevent the need for
invasive procedures.
2.Methods
The study was conducted at a Drexel University College
of Medicine outpatient oﬃce. This oﬃce is an inner-city,
single-specialty university-basedpracticecomprisedof8gas-
troenterologists and 6 gastroenterology fellows who see out-
patients with all types of gastrointestinal and liver disorders.
Two of the 8 gastroenterologists specialize in motility disor-
ders. The Drexel University College of MedicineInstitutional
Review Board approved this study.
The patients from this practice reﬂect an inner-city ter-
tiary care population. More than half of our patients are
African American and have an annual income of $25,000
or less. Approximately, a third of our patients have attended
college or higher educational degrees. An equal number of
men and women attend our practice. New patients are rou-
tinelyaskedtoﬁlloutadetailedbutgeneralreviewofsystems
while they wait to see our physician. During the visit, our
historyandphysicalforms(bothnewandfollow-up)prompt
our physicians to directly discuss a focused gastroenterology
review of systems. Our gastrointestinal review of systems
includes nine upper GI symptoms (dysphagia, odynophagia,
heartburn, dyspepsia, abdominal pain, nausea, vomiting,
melena,andweight loss)andeightlowerGIsymptoms (diar-
rhea, constipation, changes in bowel movements, decreased
stool caliber, tenesmus, urgency, bleeding, and pain). FI is
not included in either review-of-systems intake form. For
this study, FI was added to the focused gastrointestinal re-
view-of-systems intake form. Prior to the start of the study,
all gastroenterologists were notiﬁed about the addition of
FI to the standard review of systems intake form and were
reminded to ask patients about this symptom. No restric-
tions were placed on the language physicians used to discuss
this symptom with patients, with some gastroenterologists
referring to “fecal incontinence” while others using terms
such as “leakage or soiling.”
During our study period, 500 consecutive patients (both
new and returning) visiting our gastroenterology practice
were asked about FI during the gastrointestinal review of
systems. Patients who said yes were asked to enroll in the
study and underwent informed consent procedures. Physi-
cians then verbally administered three questionnaires to the
enrolled patients. The ﬁrst questionnaire included demo-
graphic factors; known medical, surgical, and obstetric risk
factors; medications; duration of symptoms; need and fre-
quency of pad or diaper use; whether FI had ever been ad-
dressed by their health care providers (The Appendix). The
second questionnaire consisted of the fecal incontinence se-
verityindex(FISI),which weusedtoassess thefrequencyand
type of stool loss. The third questionnaire consisted of the
fecal incontinence-speciﬁc American Society of Colon and
Rectal Surgeons quality of life questionnaire (FIQL), which
evaluates the impact of FI on coping, embarrassment, de-
pression, and lifestyle [18]. We chose to use these scales be-
cause they allow subjects to weigh their answers. In turn, an
external weighing scheme is employed for analysis. In addi-
tion, the validated FISI and FIQL questionnaires are easy to
use, concise, reliable, and validated [2, 19].
Our study also included a retrospective arm aimed to
identify thenumber ofpatientswho reported FIbefore itwas
included in the standardized gastrointestinal review of sys-
tems. In this part of the study, any documentation of fecal
incontinence wouldbe theresult ofindependentquestioning
by the physician or voluntary admission by the patient.
Every third chart from our ﬁle room was selected until we
reached 500 charts. We excluded patients if they had been
seen in our practice within 1 month of the start date of the
study. The selected charts were then completely reviewed for
documentationof FI during any visit. Information regarding
severity and eﬀect on QOL was not assessed in this group
because of the retrospective nature of the review.
2.1. Statistical Analysis. The data obtained was analyzed
statisticallyusing Pearson’sχ2 test alongwith95%conﬁdence
intervals (CIs) to compare groups of interest (men, women,
and combined). Logistic regression analysis was used to
identify independent associations with gender variables. A
P value of <0.05 was considered statistically signiﬁcant. We
performed additional analyses using Microsoft Excel (Red-
mond, WA) t tests for comparison of subgroup variables.
3.Results
Five-hundred individuals were approached over 3 consec-
utive months in the prospective arm of the study. Fifty-
eight (11.6%) reported symptoms of FI, and all of these pa-
tients agreed to participate in the study. Of the patients who
reported FI, 74% were women (43) and 26% were men (15)
with an average age of 51.7 years (range 22–84 years) and
an average age of onset of 48.6 years (range 17–80 years).
Approximately, 90% of the patients who reported FI had a
high school education or higher. Seventy-two percent of pa-
tients with FI had either medical or surgical risk factors for
FI.Patientcharacteristics,durationandfrequencyofinconti-
nence are summarized in Table 1.
Only2ofthe58patients(3%)intheprospectivearmpre-
sented to the oﬃce with a chief complaint of FI. The remain-
ing 56 (97%) reported incontinence only on direct question-
ing.
Thirteen of the 58 individuals (22%) had discussed
their symptoms with a physician in the past (Figure 1). OnGastroenterology Research and Practice 3
Table 1: Patient characteristics.
Patients, n 58
Female gender, n (%) 42 (74)
Patient age, years (range) 45 (22–84)
Onset age, years (range) 49 (17–80)
Education level, %
Less than high school 9.3
High school 51.8
Attended college or greater 38.9
Patients with risk factors for FI, n (%) 72
Hemorrhoids 21 (36.0)
Hysterectomya 12 (29.0)
Irritable bowel syndrome 10 (17.0)
Episiotomiesa 7 (17.0)
Forceps deliveriesa 7 (17.0)
Diabetes 9 (15.5)
Inﬂammatory bowel disease 3 (5.0)
Anorectal surgery 3 (5.0)
Spinal surgery 3 (5.0)
Rectal Prolapse 2 (3.4)
Anal ﬁssures 2 (3.4)
Scleroderma 2 (3.4)
Radiation therapy (abdomen, pelvis) 2 (3.4)
Rectal/vaginal surgerya 1(2.4)
Pelvic or rectal cancer 1(1.7)
Daily incontinence, %
Solid 17
Liquid/mucous 25
Reason for visit, n (%)
Upper GI complaints 13 (22.0)
Lower GI complaints 36 (62.0)
Liver 5 (8.6)
Anemia 2 (3.4)
FI 2 (3.4)
Duration, n (%)
Less than 5 years, n (%) 49 (84.5)
Greater than 5 years, n (%) 9 (15.5)
Use of pads, n (%) 20 (34)
Use of diapers, n (%) 8 (14)
aAssessedfor women only; percentage represents % of women only
∗Percents do not summate to 100% as many patients reported overlapping
comorbidities.
retrospective chart review, only 12 (2.4%) of 500 patients
had any mention of FI anywhere in their outpatient charts.
Gastroenterologists that specialized in motility disorders
were not more likely to ask about symptoms of FI in either
the prospective or retrospective arms of the study.
Twenty-eight of the 58 patients with FI (48%) reported a
poor quality of life (FIQL score <2.5). Each of the four FIQL
scales was independently scored. Patients with FI had a sig-
niﬁcantly lower coping score than either lifestyle score (2.31
Not asked, 78% Gastroenterologist, 12%
Unspeciﬁed, 3%
Obstetrics/g n, 3% y
Primary care
hysician, 4% p
Figure 1: Percent of patients who had previously discussed with a
physician, according to type of physician.
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Figure 2: FIQL scores. ∗Signiﬁcantly lower than lifestyle and
depression scales (P<0.006); ∗∗Signiﬁcantly lower than lifestyle
and depression scales (P<0.003).
versus 2.92, P<0.002) or depression score (2.31 versus 2.98,
P<0.003). Similarly, FI patients had a signiﬁcantly lower
embarrassment score than either lifestyle (2.37 versus 2.92,
P<0.006) or depression score (2.37 versus 2.98 P<0.001)
(Figure 2). When combined QOL scores were compared
among groups, patients with loose/watery stools had signiﬁ-
cantly lower QOL scores when compared against the groups
with formed stools (P = 0.005), alternating loose/formed
stools (P = 0.05), and all groups combined (P = 0.006)
(Table 2).
Thirty-two of 58 patients (55%) had high severity scores
(FISI score >25). When severity scores were compared
among groups, patients with formed stool had relatively
lower severity scores than all other stool-consistency groups
alone and combined, although the ﬁndings were not signiﬁ-
cant.
At the time of visit, 41 of the 58 patients with FI
(71%) reported altered stool form (loose/watery, hard, or
alternating consistency). Of FI patients with loose/watery
stool, six of 23 (26%) were taking laxatives and eleven of
23 (48%) were receiving no medical therapy at all, and only
seven of 23 FI patients (30%) were reported using antid-
iarrheal agents. See Table 2 for a summary of stool consis-
tency, medication use, severity, and quality of life scores.4 Gastroenterology Research and Practice
Table 2: Stool consistency, medication use, severity, and quality of life scores.
Consistency Medications at the time of visit Severity score Quality of life score
Loose/watery —23a
None —11 (48%)
29.5 2.26 (1.17–3.92) Laxative —6 (26%)
Antidiarrheal —7 (30%)
Formed —17
None —9 (53%)
23.8 23.8 (1.33–3.88) Laxative —6 (35%)
Anti-diarrheal —2 (12%)
Hard —6a
None —1 (17%)
29.7 29.7 (1.48–3.96) Laxative —5 (83%)
Anti-diarrheal —1 (17%)
Alternating —12
None —4 (33%)
29.8 29.8 (1.34–4.07) Laxative — 5 (42%)
Anti-diarrheal —3 (25%)
aOne person took both laxatives and antidiarrheals.
bSigniﬁcant diﬀerence between quality of life (QOL) in loose/watery stool consistency versus all other groups combined, P = 0.006, and separately (versus
formed, P = 0.005, versus alternating, P = 0.05). No signiﬁcant diﬀerence versus hard stool, P = 0.06.
Severity and QOL scores were evaluated separately for
women and men in our cohort. The average FI severity score
was not signiﬁcantly diﬀerent between men and women.
However, women had a signiﬁcantly lower average quality of
life score than men (3.04 versus 2.51; P<0.03).
Pearson correlations were calculated for men, women,
and men and women combined in regards to severity and
QOL.Formen, no signiﬁcant correlationwas found between
severity and QOL (r =− 0.09; P = 0.75; 95% CI −0.58 to
0.44). Conversely, a moderate correlation was found among
women (r =− 0.595; P< 0.001; 95% CI −0.68 to −0.36)
(Figures 3 and 4). As the severity of FI increases, therefore,
the QOL decreases in women. A moderate correlation be-
tween severity and quality of life was also found when men
and women were analyzed together (r =− 0.505; P< 0.001;
95% CI −0.68 to −0.28).
4.Discussion
AlthoughestimatesoftheoverallprevalenceofFIrange from
0.4 to 18% in the general community, it is clear that the
reported prevalence rises when patients are directly ques-
tioned about symptoms of FI. In this study, 12% of patients
reportedFIwhendirectlyasked,whereasaprevalenceofonly
2% was revealed in our retrospective arm. This latter ﬁnding
is surprising given that we conducted the study in an aca-
demic practice with expertise in motility disorders. Further-
m o r e ,t h i si st e s t a m e n tt ot h ef a c tt h a ti fd o c t o r sd on o t
ask, patients do not tell. Another unexpected ﬁnding is that
almost 40% of patients that admitted to FI had a college
educationor higher. This is in contrast to our general patient
population, in which two-thirds do not attain an education
greater than high school. The cause of this unexpected ﬁnd-
ing was unclear. One possibility is that some of our less edu-
cated patients may have misunderstood the terminology that
was usedtodescribeFI.Itisalso plausiblethatcertaingroups
of patients may be less willing to admit to FI due to the
stigma that may be associated with it. Lastly, it is possible
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Figure 3: Quality of life as a function of severity of fecal inconti-
nence in men (P = 0.75).
thatmoreeducatedindividualshavemorebothersomework-
related interruptions due to FI, which leads them to seek out
medical attention.
It was interesting that our FI patientshad a reduced QOL
predominantly as a result of issues with coping and em-
barrassment rather than depression and lifestyle issues. Al-
though not oﬃcially validated, we ultimately chose to illus-
trate FIQL as a composite score of these main scales because
we believe that the 4 scales of FIQL are simply facets of a
totalpicture.Infact,RockwooddoesstatethatwiththeFIQL
“thereisasensethattheoverallqualityoflifeisbeingassessed
which isnottrueofotherspecialized scoressuchasthosethat
assess depression or functional status.” [20] This approach
should be further investigated.
While previously published studies examine the preva-
lence of FI among men and women or women alone, none
focus onthe gender-speciﬁc eﬀe cto nQ O L .Al th o u ghn os i g -
niﬁcant diﬀerences in severity scores were found between
menandwomen,womenwithFIwerefoundtohaveasignif-
icantly lower QOL. In addition, QOL signiﬁcantly correlatedGastroenterology Research and Practice 5
Women only–QOL versus severity
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Figure 4: Quality of life as a function of severity of fecal inconti-
nence in women (P< 0.001).
w i t hs e v e r i t yi nw o m e nb u tn o ti nm e n .T h i sﬁ n d i n gr a i s e s
multiple questions. Are women more embarrassed by this
issuethan men,therebymorenegatively aﬀectingtheirquali-
tyoflife?Conversely,aremenmore embarrassed bythisissue
and thus more reluctant to report their symptoms or admit
their deteriorating QOL? Or are men less emotionally both-
ered by the soilage? Our small sample size limits our abili-
ty to make further generalizations and infer mechanistic dif-
ferences between the genders. Larger studies on FI need to
be conducted in order to uncover the relationship between
gender and quality of life.
There are many risk factors for FI; however, only stool
consistency is easily modiﬁable. That said, the best initial
approach to fecal incontinence is to identify and target treat-
ment for bowel consistency. Patients with formed stool re-
ported lower severity scores than patients with loose, hard,
oralternatingbowelpatterns.Inaddition,patientswithloose
stool had a signiﬁcantly lower QOL than patients with alter-
nating and formed stool consistencies. There are studies re-
vealing that treating diarrhea-associated fecal incontinence
with loperamide or ﬁber supplements is eﬀective in the
shortterm [21–24]. This is important considering that nearly
75% of patients who reported incontinence to loose/watery
stool had not been taking appropriate anti-diarrheal therapy,
and approximately 25% ofpatients were actually taking laxa-
tives. It should be noted that patients with fecal impaction
and resulting diarrhea and FI are generally treated with
laxatives and enemas. Whether that occurred in a subset of
our patients is unknown. Therefore, it is plausible that by
simply inquiring about stool consistency, speciﬁcally diar-
rhea, and treating appropriately a physician may avoid the
needforadditionaltestingandreferralswhilesimultaneously
contributing to a patient’s quality of life.
Our study had some potential limitations. For one, we
did not administer an overall quality of life questionnaire to
ourpatientsinanattempttolimitthenumberofsurveysthat
the patients had to complete. As a result, we are unable to
compare the quality of life of our FI patients to other popu-
lationssuchashealthyindividualsorthosethatsuﬀeredfrom
urinary incontinence [20]. In addition, it could be consid-
ered a limitation that we did not use a strict, consistent def-
inition for fecal incontinence when we approached our pa-
tientsaboutthisdisorder.Ontheotherhand,giventhevaried
levelsofeducationand communicationskills of ourpatients,
along with the sensitive nature of this issue, we felt that tai-
loring the individual interview instead of using a deﬁned
wording for FI was most appropriate.
Therefore, asking patients directly about FI can lead to
increased identiﬁcation of this debilitating condition. This
can be accomplished by prompting physicians to inquire
about FI in a targeted review of gastrointestinal symptoms.
Thisstructuredapproach willlikelyyieldahigheridentiﬁcat-
ion of FI patients. This will be especially true of physicians
who tendto forget orconsciouslyomit thissymptom in their
questioning. Furthermore, identifying and treating abnor-
mal stool consistency in patients with FI is a potential strate-
gy to reduce severity and improve quality of life. This inter-
vention is especially important in women, who are more
likely to be adversely aﬀected by the severity of their symp-
toms. Patient and physician education should be stressed to
shed light on this diﬃcult and debilitating condition.
Appendix
Background Questionnaire
Data Collection Sheet-1
Fecal incontinence: patient questionnaire
(1) Age: —
(2) Sex: [] M [] F
(3) Highest education level
[] High school
[] GED
[] College
[] Graduate/higher
(4) Reason for oﬃce visit —
(5) Bowel movements:
— Times/day — Times/week
(6) Bowel consistency:
[] Loose or watery
[] Formed
[] Hard
[] Alternating consistency
(7) Past medical history:
[] Urinary incontinence
[] Rectal prolapse
[] Hemorrhoids
[] Anal ﬁssure
[] Pelvic or rectal cancer
[] Diabetes6 Gastroenterology Research and Practice
[] Anxiety
[] Scleroderma
[] Previous Radiation therapy (in abdomen or
pelvis)
[] Irritable bowel syndrome
[] Inﬂammatory bowel disease (Crohn’s dis-
ease/Ulcerative Colitis)
[] Previous back injury
[] Parkinson’s disease
[] Amyloidosis
[] Depression
(8) Past surgical history:
[] Anorectal surgery
[] Spinal surgery
(9) Obstetric history:
Number of pregnancies —
[] Epiostomy If yes, how many? —
[] Forceps If yes, how many? —
[] Caeserian section If yes, how many? —
[] Normal vaginal delivery If yes, how many? —
(10) Have you ever experienced fecal incontinence (leak-
age of gas OR soiling with formed or liquid stool OR
smearing of undergarments)?
[] YES [] NO
Note: ifyou answered yes to question 10, then answer the
following questions, if not you are ﬁnished
(11) Age of onset of fecal incontinence —
(12) Duration of fecal incontinence:
[] Less than 1 year
[] Between 1–5 years
[] Greater than 5 years
(13) Use of pad: [] YES [] NO
(14) If yes, how often do you use pad?
—P a d sp e rd a y
— Pads per week
—P a d sp e rm o n t h
(15) Use of diaper: [] YES [] NO
(16) If yes, how often?
— Diapers per day
— Diapers per week
— Diapers per month
(17) Medications (circle as many as apply, if any):
[] Laxatives or stool softeners such as: milk of
magnesia, lactulose, bisacoydl (dulcolax), cas-
toroil, colace,psyllium (metamucil),senna (se-
nokot), sorbitol
[] Antidiarrheals such as: pepto-bismol, Imod-
ium (loepramide), lomotil (diphenoxylate)
(18) Have you ever been asked by your doctor about fecal
incontinence?
[] YES [] NO
Note: if you answered yes to question 18, please answer
the following questions.
(19) You were asked by your:
[] Family doctor/primary care
[] Gynecologist
[] Gastroenterologist
[] Surgeon
[] Other
(20) Have you everbeen evaluated/treated for fecal incon-
tinence?
[] YES [] NO
(21) If yes, you have been evaluated/treated by your:
[] Family doctor/primary care
[] Gynecologist
[] Gastroenterologist
[] Surgeon
[] Other
Acknowledgment
A portion of this manuscript was presented as a poster at Di-
gestive Disease Week.
References
[1] A. K. Macmillan, A. E. H. Merrie, R. J. Marshall, and B. R.
Parry, “The prevalence of fecal incontinence in community-
dwelling adults: a systematic review of the literature,” Diseases
of the Colon and Rectum, vol. 47, no. 8, pp. 1341–1349, 2004.
[2] N. J. Norton, “The perspective of the patient,” Gastroenterol-
ogy, vol. 126, no. 1, pp. S175–S179,2004.
[3] R.N elson,N.N ort on,E.Cautley ,andS.F urner ,“ C ommunity-
based prevalence of anal incontinence,” Journal of the Ameri-
can Medical Association, vol. 274, no. 7, pp. 559–561, 1995.
[4] R. Nelson, S. Furner, and V. Jesudason, “Fecal incontinence
in Wisconsin nursing homes prevalence and associations,”
Diseases of the Colon and Rectum, vol. 41, no. 10, pp. 1226–
1229, 1998.
[ 5 ]S .J .P r e t l o v e ,S .R a d l e y ,P .M .T o o z s - H o b s o n ,P .J .T h o m p s o n ,
A. Coomarasamy, and K. S. Khan, “Prevalence of anal incon-
tinence according to age and gender: a systematic review and
meta-regression analysis,”International Urogynecology Journal
and Pelvic Floor Dysfunction, vol. 17, no. 4, pp. 407–417, 2006.Gastroenterology Research and Practice 7
[6] W. E. Whitehead, L. Borrud, P. S. Goode et al., “Fecal incon-
tinence in US adults: epidemiology and risk factors,” Gastro-
enterology, vol. 137, no. 2, pp. 512–517.e2, 2009.
[7] A. E. Bharucha, A. R. Zinsmeister, G. R. Locke et al., “Prev-
alence and burden of fecal incontinence: a population-based
study in women,” Gastroenterology, vol. 129, no. 1, pp. 42–49,
2005.
[ 8 ]C .R .Q u a n d e r ,M .C .M o r r i s ,J .M e l s o n ,J .L .B i e n i a s ,a n dD .
A. Evans, “Prevalence of and factors associated with fecal in-
continence in a large community study of older individuals,”
American Journal of Gastroenterology, vol. 100, no. 4, pp. 905–
909, 2005.
[ 9 ] M .K .B o r e h a m ,H .E .R i c h t e r ,K .S .K e n t o ne ta l . ,“ A n a li n c o n -
tinence in women presenting forgynecologic care: prevalence,
riskfactors,andimpactuponqualityoflife,”American Journal
of Obstetrics and Gynecology, vol. 192, no. 5, pp. 1637–1642,
2005.
[10] M. G. Varma, J. S. Brown, J. M. Creasman et al., “Fecal incon-
tinence in females older than aged 40 years: who is at risk?”
Diseases of the Colon and Rectum, vol. 49, no. 6, pp. 841–851,
2006.
[11] D. Z. Bliss, S. Johnson, K. Savik, C. R. Clabots, and D. N.
Gerding, “Fecal incontinence in hospitalized patients who are
acutely ill,”Nursing Research,vol.49,no.2, pp. 101–108,2000.
[12] B. T. Hughes, P. Chepyala, S. Hendon, M. D. Crowell, and K.
W. Olden, “Fecal incontinence in an inpatient population: a
not uncommon ﬁnding,” Digestive Diseases and Sciences,v o l .
54, no. 10, pp. 2215–2219, 2009.
[13] H. Damon, O. Guye, A. Seigneurin et al., “Prevalence of anal
incontinence in adults and impact on quality-of-life,” Gas-
troenterologie Clinique et Biologique, vol. 30, no. 1, pp. 37–43,
2006.
[14] D. Gordon, A. Groutz, G. Goldman et al., “Anal incontinence:
prevalence among female patients attending a urogynecologic
clinic,”Neurourology and Urodynamics, vol.18,no. 3,pp. 199–
204, 1999.
[ 1 5 ]D .L .F a l t i n ,M .R .S a n g a l l i ,F .C u r t i n ,A .M o r a b i a ,a n dA .
Weil, “Prevalence of anal incontinence and other anorectal
symptoms in women,” International Urogynecology Journal
and Pelvic Floor Dysfunction, vol. 12, no. 2, pp. 117–121, 2001.
[16] J. F. Johanson and J. Laﬀerty, “Epidemiology of fecal inconti-
nence: the silent aﬄiction,” American Journal of Gastroenterol-
ogy, vol. 91, no. 1, pp. 33–36, 1996.
[17] T. C. F. Lam, M. L. Kennedy, F. C. Chen, D. Z. Lubowski, and
N. J. Talley, “Prevalence of faecal incontinence: obstetric and
constipation-related risk factors; a population-based study,”
Colorectal Disease,vol. 1, no. 4, pp. 197–203, 1999.
[ 1 8 ]T .H .R o c k w o o d ,J .M .C h u r c h ,J .W .F l e s h m a ne ta l . ,“ F e c a l
Incontinence Quality of Life Scale. Quality of life instrument
for patients with fecal incontinence,” Diseases of the Colon and
Rectum, vol. 43, no. 1, pp. 9–17, 2000.
[19] S. K. Hawes and A. Ahmad, “Fecal incontinence: a woman’s
view,”American Journal ofGastroenterology,vol.101,no.3,pp.
S610–S617, 2006.
[20] T. H. Rockwood, “Incontinence Severity and QOL Scales for
Fecal Incontinence,” Gastroenterology, vol. 126, no. 1, pp.
S106–S113, 2004.
[21] J. S. Kalantar, S. Howell, and N. J. Talley, “Prevalence of faecal
incontinence and associated risk factors: an underdiagnosed
problem in the Australian community?” Medical Journal of
Australia, vol. 176, no. 2, pp. 54–57, 2002.
[22] P. S. Goode, K. L. Burgio, A. D. Halli et al., “Prevalence and
correlates of fecal incontinence in community-dwelling older
adults,” Journal of the American Geriatrics Society, vol. 53, no.
4, pp. 629–635, 2005.
[23] K. R. Palmer, C. L. Corbett, and C. D. Holdworth, “Double-
blind cross-over study comparing loperamide codeine and di-
phenoxylate in the treatment of chronic diarrhea,” Gastroen-
terology, vol. 79, no. 6, pp. 1272–1275, 1980.
[24] D. Z. Bliss, H. J. Jung, K. Savik et al., “Supplementation with
dietary ﬁber improves fecal incontinence,” Nursing Research,
vol. 50, no. 4, pp. 203–213, 2001.